" class="no-js "lang="en-US"> Lengo Therapeutics - Medtech Alert
Sunday, February 05, 2023
Lengo Therapeutics | Pharmtech Focus

Lengo Therapeutics

About Lengo Therapeutics

Lengo Therapeutics

Lengo Therapeutics is a biopharmaceutical company committed to developing novel, best-in-class precision medicines targeting driver mutations in oncology to improve the lives of patients with cancer.

Related Story

Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics

November 29 2021

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the company has entered into a definitive agreement […]